1. Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2011;60(4):742–50.
2. Kessler TM, La Framboise D, Trelle S, Fowler CJ, Kiss G, Pannek J, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol. 2010;58(6):865–74.
3. Delaere KP, Debruyne FM, Michiels HG, Moonen WA. Prolonged bladder distension in the management of the unstable bladder. J Urol. 1980;124(3):334–7.
4. Iwatsubo E, Komine S, Yamashita H, Imamura A, Akatsu T. Over-distension therapy of the bladder in paraplegic patients using self-catheterisation: a preliminary study. Paraplegia 1984;22(4):210–5.
5. Wada N, Shimizu T, Takai S, Shimizu N, Kanai AJ, Tyagi P, et al. Post-injury bladder management strategy influences lower urinary tract dysfunction in the mouse model of spinal cord injury. Neurourol Urodyn. 2017;36(5):1301–5.